Shares of HCA Healthcare, Inc. (NYSE:HCA – Get Rating) have been assigned an average rating of “Moderate Buy” from the twenty-two research firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and eleven have issued a buy recommendation on the company. The average 1-year target price among analysts that have covered the stock in the last year is $245.05.
Several research firms have recently issued reports on HCA. Citigroup increased their price objective on shares of HCA Healthcare from $240.00 to $251.00 and gave the company a “buy” rating in a report on Wednesday, October 26th. SVB Leerink raised their target price on shares of HCA Healthcare from $238.00 to $286.00 and gave the stock an “outperform” rating in a report on Friday, December 16th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, December 7th. The Goldman Sachs Group raised their price target on shares of HCA Healthcare from $233.00 to $265.00 and gave the company a “buy” rating in a report on Monday, December 12th. Finally, Raymond James decreased their price target on shares of HCA Healthcare from $250.00 to $230.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 25th.
Insiders Place Their Bets
In other HCA Healthcare news, insider A Bruce Moore, Jr. sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $224.07, for a total transaction of $2,240,700.00. Following the completion of the transaction, the insider now owns 30,807 shares in the company, valued at approximately $6,902,924.49. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, insider A Bruce Moore, Jr. sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $224.07, for a total transaction of $2,240,700.00. Following the completion of the sale, the insider now owns 30,807 shares of the company’s stock, valued at approximately $6,902,924.49. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Kathryn A. Torres sold 2,000 shares of the firm’s stock in a transaction that occurred on Monday, October 24th. The stock was sold at an average price of $203.30, for a total transaction of $406,600.00. Following the sale, the senior vice president now directly owns 20,372 shares of the company’s stock, valued at approximately $4,141,627.60. The disclosure for this sale can be found here. In the last 90 days, insiders sold 30,170 shares of company stock worth $6,700,630. 1.50% of the stock is currently owned by insiders.
Institutional Trading of HCA Healthcare
HCA Healthcare Trading Up 0.2 %
NYSE HCA opened at $250.40 on Wednesday. HCA Healthcare has a 52 week low of $164.47 and a 52 week high of $279.02. The stock has a market cap of $70.79 billion, a price-to-earnings ratio of 14.15, a price-to-earnings-growth ratio of 1.93 and a beta of 1.65. The company has a 50-day moving average price of $235.21 and a two-hundred day moving average price of $212.32.
HCA Healthcare (NYSE:HCA – Get Rating) last posted its earnings results on Friday, October 21st. The company reported $3.93 EPS for the quarter, topping the consensus estimate of $3.89 by $0.04. HCA Healthcare had a net margin of 8.99% and a negative return on equity of 118,372.40%. The firm had revenue of $14.97 billion during the quarter, compared to analysts’ expectations of $15 billion. During the same quarter in the prior year, the firm earned $4.57 EPS. HCA Healthcare’s quarterly revenue was down 2.0% on a year-over-year basis. As a group, equities research analysts expect that HCA Healthcare will post 16.96 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, December 28th. Shareholders of record on Wednesday, December 14th were issued a dividend of $0.56 per share. The ex-dividend date of this dividend was Tuesday, December 13th. This represents a $2.24 annualized dividend and a yield of 0.89%. HCA Healthcare’s payout ratio is 12.66%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
- Get a free copy of the StockNews.com research report on HCA Healthcare (HCA)
- Is Salesforce’s New Rally The Beginning Of A Big Uptrend?
- Can Lockheed Martin Corporation Hit Another All-Time High in Q1?
- Marathon Digital Holdings, Inc: Slow And Steady Wins The Race
- The WD-40 Company Is Ready To Rebound, But Will It?
- Skechers Not Nike Is The Sneaker Stock to Own for 2023
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.